top of page
Could a New Experiment Treatment Help With Peanut Allergy?
Phase 1A / 2A Clinical Trial
We're inviting adults with peanut allergy to join a research study testing a new experimental therapy called UKK-0018. This is the first time it has been tested in people. It is given as an injection in the muscle. All visits and study treatments are free, and you will be reimbursed for your time.
Am I Eligible?
Between 18 and 55 years old
Diagnosed with peanut allergy by a doctor
A skin test has shown you react to peanut
A blood test has shown you have a peanut allergy
Had a reaction to peanut during a supervised test at your screening visit
Must be able to commit to attending all study visits for the full study
QR Code
Talk to Our
Study Team
Scan the QR code or contact your nearest participating site t find out more or register your interest. Taking part is completely voluntary. You can choose not to join, or withdraw at any time, without it affecting your medical care.
Contact Us At:
Australia
Royal Prince Alfred Hospital (RPAH), New South Wales, Australia
Contact: Alex.Stoyanov@health.nsw.gov.au
Flinders Medical Centre (FMC), South Australia, Australia
Email: Health.ResearchHubCT@sa.gov.au
Royal Melbourne Hospital (RMH), Victoria, Australia
Email: allergyresearch@mh.org.au
Fiona Stanley Hospital / Linear Clinical Research, Western Australia, Australia
Contact: Lucy Glazov | Phone: +61 (0)478 603 794
Email: fshimmunology.research@health.wa.gov.au
New Zealand
PCRN - Momentum, Auckland, New Zealand
Email: UKKO-18-101.taka@momcr.co.nz
bottom of page